About Us
Washington Post Ad Sunday 7/15/07 “DYSFUNCTION AT THE FDA” 12″x10.5″
CareToLive began as an advocacy group for men with late stage prostate cancer.
1 in every 6 men will get prostate cancer in their lifetime.
Each year over 218,000 men are diagnosed with prostate cancer.
96,000 men will progress to late stage or Androgen Independent prostate cancer (AIPC).
30,000 men will die of prostate cancer each year.
Only one drug has been approved which showed some survival benefits in the treatment of late stage androgen independent prostate cancer in over 42 years ago. It is so toxic and disruptive that most men refuse it.
The Dendreon Corporation has created a treatment called Provenge, an immunotherapy, that has shown it increases survival. The FDA saw the survival, granted Provenge Fast-Track Status, and then called together a panel of 17 experts to advise them on whether Provenge should be approved. The panel did indeed advise them.
By a vote of 17-0 the panel told them that Provenge is safe. By a vote of 13-4 the panel told them that Provenge shows substantial evidence of efficacy. The FDA decided to go against the panel of experts and delayed approval, an unprecedented act given that there are no viable alternatives in a treatment that was voted so overwhelmingly positive which showed survival benefits.
CareToLive sprang up as a result of this terrible decision. We have been going to bat for men with prostate cancer ever since.
We wrote thousands of letters to our elected officials, took out a half page ad in the Washington Post, organized and / or attended 3 rallies, and rolled out 2 fleets of buses with billboard letting the FDA know that we want Provenge Approved NOW! Our Attorney, Kerry Donahue, has filed a lawsuit on behalf of our membership who seek immediate access to Provenge for all eligible men.
We are currently wending our way through Federal Court, against a bevy of Department of Justice Attorneys representing the FDA, fighting us tooth and nail to avoid explaining themselves hoping they can continue their charade that they are looking out for our health and welfare.
Please help us in our battle against our dysfunctional FDA as we fight to get to the bottom of this, to try to gain access to Provenge for men with late stage prostate cancer as quickly as humanly possible.
Popularity: 2%